Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Cancer Research|May 4, 2005
Antimetastatic activity of a novel mechanism-based gelatinase inhibitorAchim Krüger, Matthias J E Arlt, Michael Gerg, et al.Chemical Biology & Drug Design|November 28, 2018
Characterization and regulation of MT1-MMP cell surface-associated activitySonia Pahwa, Manishabrata Bhowmick, Sabrina Amar, et al.Frontiers in Oncology|October 5, 2020
Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor ResistanceCoralie Reger de Moura, Marco Prunotto, Anjum Sohail, et al.Cancer Cell International|September 22, 2021
Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressivenessR Daniel Bonfil, Wei Chen, Semir Vranic, et al.Chemical Biology & Drug Design|October 12, 2007
Metabolism of a highly selective gelatinase inhibitor generates active metaboliteMijoon Lee, Adriel Villegas-Estrada, Giuseppe Celenza, et al.Chemical Biology & Drug Design|October 8, 2009
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinasesChristopher Forbes, Qicun Shi, Jed F Fisher, et al.Journal of the National Cancer Institute|January 5, 2002
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasisJeffrey A Nemeth, Rafid Yousif, Michael Herzog, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasisMichael L Cher, Hector R Biliran, Sunita Bhagat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancerWilhelm J Lubbe, Zengyi Y Zhou, Weili Fu, et al.Matrix Biology : Journal of the International Society for Matrix Biology|December 19, 2006
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cellsKulrut Borrirukwanit, Marc A Lafleur, Francesca A Mercuri, et al.Pageof 9